NeueHealth, Inc. (NEUE)
NYSE: NEUE · Real-Time Price · USD
5.07
+0.12 (2.32%)
Nov 21, 2024, 3:55 PM EST - Market closed

NeueHealth Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for NeueHealth stock has a target of 8.00, which predicts an increase of 57.95% from the current stock price of 5.07.

Analyst Consensus: Hold
Target Low Average Median High
Price $8.00 $8.00 $8.00 $8.00
Change +57.95% +57.95% +57.95% +57.95%
* Price targets were last updated on Mar 13, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for NeueHealth is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24
Strong Buy 00
Buy 00
Hold 11
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Hold
Maintains
$7$8
Hold Maintains $7$8 +57.95% Mar 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
987.40M
Revenue Next Year
1.09B
from 987.40M
Increased by 10.49%
EPS This Year
-15.70
from -150.94
EPS Next Year
-12.16
from -15.70
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
-----987.40M1.09B
Revenue Growth
114.86%83.45%193.86%-50.35%54.53%-10.49%
EPS
-74.56-145.94-241.66-190.04-150.94-15.70-12.16
EPS Growth
-------
Forward PE
-------
No. Analysts -----55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 1.1B 1.2B
Avg 987.4M 1.1B
Low 930.0M 987.4M

Revenue Growth

Revenue Growth 20242025
High -
20.7%
Avg -
10.5%
Low -
-0.0%

EPS Forecast

EPS 20242025
High -16.16 -9.51
Avg -15.70 -12.16
Low -15.08 -14.48

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.